Impact of HMGB1, RAGE, and TLR4 in Alzheimer's disease (AD): from risk factors to therapeutic targeting
Alzheimer's disease (AD) is a devastating neurodegenerative disorder and a leading cause
of dementia, with accumulation of amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) as …
of dementia, with accumulation of amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) as …
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Neuroinflammation is one of the host defensive mechanisms through which the nervous
system protects itself from pathogenic and or infectious insults. Moreover, neuroinflammation …
system protects itself from pathogenic and or infectious insults. Moreover, neuroinflammation …
High mobility group box-1 and blood–brain barrier disruption
M Nishibori, D Wang, D Ousaka, H Wake - Cells, 2020 - mdpi.com
Increasing evidence suggests that inflammatory responses are involved in the progression
of brain injuries induced by a diverse range of insults, including ischemia, hemorrhage …
of brain injuries induced by a diverse range of insults, including ischemia, hemorrhage …
HMGB1-mediated neuroinflammatory responses in brain injuries: potential mechanisms and therapeutic opportunities
Brain injuries are devastating conditions, representing a global cause of mortality and
morbidity, with no effective treatment to date. Increased evidence supports the role of …
morbidity, with no effective treatment to date. Increased evidence supports the role of …
Neuro-inflammation modulation and post-traumatic brain injury lesions: from bench to bed-side
Head trauma is the most common cause of disability in young adults. Known as a silent
epidemic, it can cause a mosaic of symptoms, whether neurological (sensory–motor …
epidemic, it can cause a mosaic of symptoms, whether neurological (sensory–motor …
Post-traumatic epilepsy and comorbidities: advanced models, molecular mechanisms, biomarkers, and novel therapeutic interventions
Post-traumatic epilepsy (PTE) is one of the most devastating long-term, network
consequences of traumatic brain injury (TBI). There is currently no approved treatment that …
consequences of traumatic brain injury (TBI). There is currently no approved treatment that …
Neuroinflammation in post-traumatic epilepsy: pathophysiology and tractable therapeutic targets
Epilepsy is a common chronic consequence of traumatic brain injury (TBI), contributing to
increased morbidity and mortality for survivors. As post-traumatic epilepsy (PTE) is drug …
increased morbidity and mortality for survivors. As post-traumatic epilepsy (PTE) is drug …
Potential neuroprotective effect of the HMGB1 inhibitor glycyrrhizin in neurological disorders
Glycyrrhizin (glycyrrhizic acid), a bioactive triterpenoid saponin constituent of Glycyrrhiza
glabra, is a traditional medicine possessing a plethora of pharmacological anti-inflammatory …
glabra, is a traditional medicine possessing a plethora of pharmacological anti-inflammatory …
HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury
SW Tan, Y Zhao, P Li, YL Ning, ZZ Huang… - Journal of …, 2021 - Springer
Background Cognitive impairment in the late stage of traumatic brain injury (TBI) is
associated with the NOD-, LRR and pyrin domain-containing protein 3 (NLRP3) …
associated with the NOD-, LRR and pyrin domain-containing protein 3 (NLRP3) …
HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target
D Mao, Y Zheng, F Xu, X Han, H Zhao - Frontiers in Neurology, 2022 - frontiersin.org
High-mobility group box-1 (HMGB1) is a nuclear protein associated with early inflammatory
changes upon extracellular secretion expressed in various cells, including neurons and …
changes upon extracellular secretion expressed in various cells, including neurons and …